Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. [electronic resource]
Producer: 20010726Description: 241-3 p. digitalISSN:- 0006-4971
- Acute Disease
- Angiogenesis Inhibitors -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Bone Marrow Cells -- chemistry
- Endothelium, Vascular -- chemistry
- Female
- Humans
- Immunohistochemistry
- Indoles -- administration & dosage
- Leukemia, Myeloid -- drug therapy
- Middle Aged
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrroles -- administration & dosage
- Receptor Protein-Tyrosine Kinases -- drug effects
- Receptors, Growth Factor -- drug effects
- Receptors, Vascular Endothelial Growth Factor
- Remission Induction -- methods
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.